Log in to search using one of your social media accounts:

 

Dead is dead: Drug for helping smokers quit found to increase risk of heart attack AND self-harm

(Natural News) Pfizer’s flagship smoking cessation drug varenicline, sold under the brand names Chantix in the United States and Champix in Canada and Europe, may do more harm than good as recent research published in the American Journal of Respiratory and Critical Care Medicine showed that the medication was associated with an increased likelihood of suffering from cardiovascular conditions. A...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news

Related Links:

CONCLUSION: Decreased SpO2 was a significant predictor of abnormal mitral Doppler flow. Diastolic dysfunction should be considered when SpO2 ≤ 95% is found. PMID: 29671629 [PubMed - as supplied by publisher]
Source: Scandinavian Cardiovascular Journal - Category: Cardiology Tags: Scand Cardiovasc J Source Type: research
Authors: Bath PM, May J, Heptinstall S Abstract Vascular diseases such as myocardial infarction and ischemic stroke are associated with increased platelet function whilst the risk of recurrence is reduced by antiplatelet agents such as aspirin, clopidogrel, and prasugrel. However, some patients exhibit high platelet reactivity, especially with clopidogrel. Existing platelet function tests may not be ideal in that they can be expensive, are often time consuming, and measurements must be made near to the patient and within a few hours of blood collection. Platelet activation leads to translocation of P-selectin from ...
Source: Platelets - Category: Hematology Tags: Platelets Source Type: research
Those with a normal BMI (an estimate of overall body fat based on height and weight) but high levels of belly fat were about twice as likely to have a heart attack, procedures to open blocked arteries, or to die from heart problems during the follow-up than people without belly fat.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Having a belly that is bigger than your waist makes you two-fold more likely to have a major heart even than if you were just overweight or obese, according to new Mayo Clinic research.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
It ’ s not always easy to tell if you have heart disease or have had a heart attack.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Heart Tests (Medical) O'Donnell, Rosie Source Type: news
CONCLUSION: In this consecutive real-world cohort of patients, the DCS was safe and efficacious when used for PPCI in patients with STEMI. PMID: 29666900 [PubMed - as supplied by publisher]
Source: Herz - Category: Cardiology Tags: Herz Source Type: research
Objective. We evaluated the relationship between various risk scores (SYNTAX score (SS), SYNTAX score-II (SS-II), thrombolysis in myocardial infarction (TIMI) risk scores and Global Registry of Acute Coronary Events (GRACE) risk scores) and major adverse cardiovascular events (MACE) in non-ST-elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI). Subjects and Methods: The study population were selected from among 589 patients who underwent coronary angiography with a diagnosis of NSTEMI. TIMI and GRACE risk scores were calculated. SS and SS-II were calculated in all patients,...
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
Diabetes mellitus (DM) is a kind of severe disorder since it strongly increases the risk of cardiovascular complications, such as coronary artery disease, myocardial infarction, hypertension, and dyslipidemia [1 –3]. In 2015 it was estimated that there were 415 million (uncertainty interval: 340–536 million) people with diabetes aged 20-79 years, 5.0 million deaths attributable to diabetes, and the total global health expenditure due to diabetes was estimated at 673 billion US dollars. Three quarters (7 5%) of those with diabetes were living in low-and middle-income countries, lacking of primary care.
Source: Primary Care Diabetes - Category: Primary Care Authors: Tags: Original research Source Type: research
ConclusionsControlled clinical trials are needed to determine which populations may profit from more frequent potassium-monitoring and subsequent interventions, e.g., change or withdrawal of potassium-influencing drugs, in order to restore normal values and prevent cardiovascular outcomes.Registration DetailsRegistration in PROSPERO (Centre for Reviews and Dissemination University of York, York, UK): CRD42016048897 (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=48897).
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
This post was written by Tarissa Lai, one of our outstanding EM residents at Hennepin County Medical Center, with comments by Steve Smith and Dan Lee.CaseA 30 something y.o. female with HTN, HLD, diabetes, ESRD on dialysis is brought in by EMS with sudden onset, left -sided chest pain for the past four hours.This is her pre-hospital ECG: This is her first ECG in the ED:What do you think?I interpreted this as normal sinus rhythm with LVH, but no significantly peaked T waves concerning for hyperkalemia. I did not appreciate any significant ST elevation.However, the prehospital ECG is more worrisome:the T-...
Source: Dr. Smith's ECG Blog - Category: Cardiology Authors: Source Type: blogs
More News: Canada Health | Cardiology | Cardiovascular | Chantix | Heart | Heart Attack | Pfizer | Respiratory Medicine | Smokers | USA Health